Maria T. Bruno

Via S Sofia 78
Catania, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Is active surveillance of CIN2 always appropriate? Clinical outcomes and factors associated with progression and regression over 48 months in an HPV-positive cohort.

Is active surveillance of CIN2 always appropriate? Clinical outcomes and factors associated with progression and regression over 48 months in an HPV-positive cohort.

Journal: BMC cancer
Published: March 26, 2026

Persistent Low-Grade Squamous Intraepithelial Lesions and the Risk of Overtreatment: Evidence from Long-Term Active Surveillance.

Persistent Low-Grade Squamous Intraepithelial Lesions and the Risk of Overtreatment: Evidence from Long-Term Active Surveillance.

Journal: Cancers
Published: February 05, 2026

From Transition to Reproduction: A Narrative Review of Evolving Evidence in Transgender Obstetrics and Gynecology.

From Transition to Reproduction: A Narrative Review of Evolving Evidence in Transgender Obstetrics and Gynecology.

Journal: Gynecologic and obstetric investigation
Published: December 07, 2025

CIN2 and Active Surveillance: Evidence from 48-Month Follow-Up in an HPV-Positive Cohort.

CIN2 and Active Surveillance: Evidence from 48-Month Follow-Up in an HPV-Positive Cohort.

Journal: Cancers
Published: October 26, 2025

Locally Advanced Cervical Cancer: Multiparametric MRI in Gynecologic Oncology and Precision Medicine.

Locally Advanced Cervical Cancer: Multiparametric MRI in Gynecologic Oncology and Precision Medicine.

Journal: Diagnostics (Basel, Switzerland)
Published: September 19, 2025

CIN2 in the Era of Risk-Based Management and HPV Vaccination: Epidemiology, Natural History and Guidelines.

CIN2 in the Era of Risk-Based Management and HPV Vaccination: Epidemiology, Natural History and Guidelines.

Journal: Diagnostics (Basel, Switzerland)
Published: September 02, 2025

Imaging Biomarkers for HER2-Positive Breast Cancer: Evidence from an Observational Study.

Imaging Biomarkers for HER2-Positive Breast Cancer: Evidence from an Observational Study.

Journal: Journal of clinical medicine
Published: June 01, 2025

Endocervical Curettage and Extended HPV Genotyping as Predictors of Residual Disease After Hysterectomy in Postmenopausal Women Previously Treated with LEEP for CIN3: A Multivariate Analysis.

Endocervical Curettage and Extended HPV Genotyping as Predictors of Residual Disease After Hysterectomy in Postmenopausal Women Previously Treated with LEEP for CIN3: A Multivariate Analysis.

Journal: Cancers
Published: May 14, 2025

Role of endocervical curettage in detecting CIN2 + in postmenopausal women with persistent high-risk HPV and type 3 transformation zone.

Role of endocervical curettage in detecting CIN2 + in postmenopausal women with persistent high-risk HPV and type 3 transformation zone.

Journal: BMC cancer
Published: May 02, 2025

Magnetic Resonance Imaging in the Management of Women with Low-Risk Early-Stage Cervical Cancer: A Narrative Review.

Magnetic Resonance Imaging in the Management of Women with Low-Risk Early-Stage Cervical Cancer: A Narrative Review.

Journal: Diagnostics (Basel, Switzerland)
Published: February 08, 2025

Vaginal Intraepithelial Neoplasia (VaIN) after Hysterectomy Is Strongly Associated with Persistent HR-HPV Infection.

Vaginal Intraepithelial Neoplasia (VaIN) after Hysterectomy Is Strongly Associated with Persistent HR-HPV Infection.

Journal: Cancers
Published: May 28, 2024

Cervical Intraepithelial Neoplasia Grade 3 (CIN3) in Women Younger than 30 Years Was Significantly Associated with HPV16/18 Genotypes.

Cervical Intraepithelial Neoplasia Grade 3 (CIN3) in Women Younger than 30 Years Was Significantly Associated with HPV16/18 Genotypes.

Journal: Cancers
Published: May 03, 2024
Showing 1-12 of 36

Last Updated: 09/26/2026